(MENAFN- EIN Presswire)
Listeria Monocytogenes Infections treatment Global market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company has updated all its market reports with the latest information for the year 2024, projecting trends and forecasts until 2033
The Business Research Company has updated all its market reports with the latest information for the year 2024, projecting trends and forecasts until 2033” - The Business Research Company
LONDON, GREATER LONDON, UK, June 17, 2024 /EINPresswire / -- The Listeria monocytogenes infections treatment market size has shown robust growth in recent years, rising from $4.52 billion in 2023 to an estimated $4.79 billion in 2024, at a compound annual growth rate (CAGR) of 5.9%. This growth can be attributed to increased food safety regulations, a rise in the incidence of foodborne illnesses, advancements in diagnostics, and heightened awareness through education and healthcare infrastructure development.
Rising Incidence of Foodborne Diseases Drives Market Growth
The increasing prevalence of foodborne diseases, including those caused by Listeria monocytogenes, continues to propel the expansion of the infections treatment market. Listeria monocytogenes, a bacterium found in contaminated food and beverages, poses significant health risks. Effective treatment mitigates these risks, reducing severity and potential complications associated with listeriosis. According to the European Food Safety Authority, there was a notable 29.8% increase in foodborne incidents in 2021 compared to the previous year, underscoring the urgency of effective treatment solutions.
Explore the global Listeria monocytogenes infections treatment market with a detailed sample report:
Key Players and Market Trends
Major companies driving innovation in the Listeria monocytogenes infections treatment market include Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., and Novartis AG. These companies focus on developing advanced therapeutic products and diagnostic solutions to enhance treatment efficacy and patient outcomes. For instance, Gold Standard Diagnostics launched Microgen Listeria-ID, a rapid microbiological test designed to identify Listeria species in food processing environments, highlighting advancements in diagnostic capabilities.
Segments
. Drug Class: Ampicillin, Gentamicin, Vancomycin, Other Drug Classes
. Type of Infection: Gastroenteritis, Endocarditis, Meningitis, Bacteremia, Brain Abscess
. Mode of Administration: Oral, Injectable, Other Modes of Administration
. End Users: Hospitals, Home Care, Specialty Clinics, Other End Users
Geographical Insights: North America Leading the Market
North America emerged as the largest region in the Listeria monocytogenes infections treatment market in 2023. The region's dominance is driven by advanced healthcare infrastructure, stringent regulatory frameworks, and significant investments in research and development. Comprehensive insights into regional dynamics and growth opportunities are detailed in the complete report.
Access the complete report for an in-depth analysis of the global Listeria monocytogenes infections treatment market:
Listeria Monocytogenes Infections Treatment Global Market Report 2024 from TBRC covers the following information:
.Market size date for the forecast period: Historical and Future
.Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
.Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Listeria Monocytogenes Infections Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on listeria monocytogenes infections treatment market size, listeria monocytogenes infections treatment market drivers and trends, listeria monocytogenes infections treatment market major players, competitors' revenues, market positioning, and market growth across geographies. The listeria monocytogenes infections treatment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Complicated Skin And Skin Structure Infections Drugs Global Market Report 2024
report/complicated-skin-and-skin-structure-infections-drugs-global-market-report
Sexually Transmitted Infections (STIs) Global Market Report 2024
report/sexually-transmitted-infections-stis-global-market-report
Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024
report/pseudomonas-aeruginosa-infection-treatment-global-market-report
About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company's flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: ...
Check out our:
LinkedIn:
Twitter:
Facebook:
YouTube:
Blog:
Healthcare Blog:
Global Market Model: global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
...
Visit us on social media:
Facebook
X
LinkedIn
MENAFN17062024003118003196ID1108342113
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.